Faslodex Registry: a Belgian Observational Study to Evaluate the Use of Fulvestrant in Current Clinical Practice.
Phase of Trial: Phase IV
Latest Information Update: 25 Dec 2009
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2008 Status changed from not yet recruiting to recruiting, based on information from ClinicalTrials.gov.
- 05 Sep 2008 New trial record.